BioMark Completes Data Collection And Submits Data for Analysis prior to Health Canada Submission – Biomark Diagnostics

News

July 5, 2016

BioMark Completes Data Collection And Submits Data for Analysis prior to Health Canada Submission

BioMark Diagnostics Inc.

BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

BioMark Announce Progress Towards Data Analysis (PDF)

Share this post:

Categories

Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.

CSE: BUX
OTC: BMKDF
FSE: 20B

More Information

Investors

Related articles ...

News

BIOMARK RECEIVES $825K GRANT TO DEVELOP ITS LIQUID BIOPSY ASSAY FOR LUNG CANCER SCREENING

Vancouver, British Columbia – (June 1st, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

June 1, 2021

News

BIOMARK REÇOIT UNE SUBVENTION DE 825 K $ POUR DÉVELOPPER SON TEST DE BIOPSIE LIQUIDE POUR LE DÉPISTAGE DU CANCER DU POUMON

Vancouver, Colombie-Britannique – (1er juin 2021) – BioMark Diagnostics Inc. («BioMark») (CSE: BUX) (FSE: 20B)

June 1, 2021

News

BIOMARK ANNOUNCES CHANGE OF AUDITOR

Vancouver, British Columbia – (May 31, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

May 31, 2021

biomark diagnostics liquid biopsy test tubes with dna blood samples

Articles and Information

Liquid Biopsy – What Is It?

A liquid biopsy is a test that is performed on a sample of blood taken

May 26, 2021

buy-hold-10-reasons-biomark-stock

Articles and Information

10 Reasons why Biomark BUX is a Buy and Long-term Hold

The article presented on this page may contain forward-looking statements. These statements relate to future

May 20, 2021

1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2

Pages

Latest Posts

Site Policies

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.